| Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma V Kunzmann, E Bauer, J Feurle, FWHP Tony, M Wilhelm Blood, The Journal of the American Society of Hematology 96 (2), 384-392, 2000 | 874 | 2000 |
| γδ T cells for immune therapy of patients with lymphoid malignancies M Wilhelm, V Kunzmann, S Eckstein, P Reimer, F Weissinger, T Ruediger, ... Blood 102 (1), 200-206, 2003 | 714 | 2003 |
| Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study P Reimer, T Rüdiger, E Geissinger, F Weissinger, C Nerl, N Schmitz, ... Journal of Clinical Oncology 27 (1), 106-113, 2009 | 516 | 2009 |
| What is CD4+ CD56+ malignancy and how should it be treated? P Reimer, T Rüdiger, D Kraemer, V Kunzmann, F Weissinger, A Zettl, ... Bone marrow transplantation 32 (7), 637-646, 2003 | 209 | 2003 |
| Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German … WJ Heinz, D Buchheidt, M Christopeit, M von Lilienfeld-Toal, OA Cornely, ... Annals of hematology 96, 1775-1792, 2017 | 185 | 2017 |
| Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular … A Lorch, C Kollmannsberger, JT Hartmann, B Metzner, IGH Schmidt-Wolf, ... Journal of Clinical Oncology 25 (19), 2778-2784, 2007 | 154 | 2007 |
| Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings F Weissinger, BM Sandmaier, DG Maloney, WI Bensinger, T Gooley, ... Blood, The Journal of the American Society of Hematology 98 (13), 3584-3588, 2001 | 137 | 2001 |
| Central venous catheter-related infections in hematology and oncology: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and … HH Wolf, M Leithäuser, G Maschmeyer, H Salwender, U Klein, I Chaberny, ... Annals of hematology 87, 863-876, 2008 | 112 | 2008 |
| Parathyroid hormone-related protein-associated hypercalcemia in a patient with CLL type low grade leukemic B-cell lymphoma B Schottker, W Heinz, F Weissinger, K Sozener, M Eck, J Seufert Haematologica 91 (12_Suppl), ECR45-ECR45, 2006 | 110 | 2006 |
| Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party … B Böll, E Schalk, D Buchheidt, J Hasenkamp, M Kiehl, TR Kiderlen, ... Annals of hematology 100, 239-259, 2021 | 106 | 2021 |
| A role for NF-κB in organ specific cancer and cancer stem cells C Kaltschmidt, C Banz-Jansen, T Benhidjeb, M Beshay, C Förster, ... Cancers 11 (5), 655, 2019 | 100 | 2019 |
| Central venous catheter (CVC)-related infections in neutropenic patients: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and … G Fätkenheuer, D Buchheidt, OA Cornely, HG Fuhr, M Karthaus, J Kisro, ... Annals of Hematology 82, S149-S157, 2003 | 93 | 2003 |
| Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: analysis of REACH trial results by Child-Pugh score AX Zhu, AD Baron, P Malfertheiner, M Kudo, S Kawazoe, D Pezet, ... JAMA oncology 3 (2), 235-243, 2017 | 91 | 2017 |
| Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised … S Lorenzen, JR Knorrenschild, GM Haag, M Pohl, P Thuss-Patience, ... European Journal of Cancer 51 (5), 569-576, 2015 | 75 | 2015 |
| Interaction of human hematopoietic stem cells with bacterial pathogens A Kolb-Mäurer, M Wilhelm, F Weissinger, EB Bröcker, W Goebel Blood, The Journal of the American Society of Hematology 100 (10), 3703-3709, 2002 | 73 | 2002 |
| Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute … U Platzbecker, C Thiede, M Füssel, G Geissler, T Illmer, B Mohr, M Hänel, ... Leukemia 20 (4), 707-714, 2006 | 71 | 2006 |
| Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a … P Reimer, T Schertlin, T Rüdiger, E Geissinger, S Roth, V Kunzmann, ... The Hematology Journal: the Official Journal of the European Haematology …, 2004 | 71 | 2004 |
| Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II … M Moehler, I Gepfner-Tuma, A Maderer, PC Thuss-Patience, J Ruessel, ... BMC cancer 16, 1-13, 2016 | 64 | 2016 |
| Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the … M Christopeit, M Schmidt-Hieber, R Sprute, D Buchheidt, M Hentrich, ... Annals of hematology 100, 321-336, 2021 | 58 | 2021 |
| Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and … M Ruhnke, OA Cornely, M Schmidt‐Hieber, N Alakel, B Boell, ... Mycoses 63 (7), 653-682, 2020 | 56 | 2020 |
